Skip to content

Medical-device intelligence

Therakos Inc: FDA clearances and recalls

Research Therakos Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

0 clearance records and 8 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Jul 18, 2006 to Oct 4, 2021.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
LNR · System, Photopheresis, Extracorporeal08

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

8 matching records
Device / recordCompany in FDA recordSourceSource date
THERAKOS CELLEX Photopheresis Procedural Kit PRODUCT CODE: CLXUSAZ-0212-2022 · LNRTherakos, Inc.RecallNov 5, 2021FDA record creation date
The THERAKOS CELLEX Photopheresis System is a photoimmune therapy. Catalog CLXUSA. Manufacturing lot D342 UDI: 20705030200003 The system designe…Z-1322-2016 · LNRTherakos IncRecallApr 5, 2016FDA record creation date
Therakos Cellex Photopheresis System CellexUSA & Cellex. The photopheresis system is indicated for use in the ultraviolet-A (UVA) irradiation in…Z-0595-2012 · LNRTherakos, Inc.RecallJan 11, 2012FDA classification date
XT125 PHOTOPHERESIS PROCEDURAL KIT FOR USE WITH THE UVAR XTS INSTRUMENT; XT001 PHOTOPHERESIS PROCEDURAL KIT FOR USE WITH THE UVAR XTS INSTRUMENT …Z-2994-2011 · LNRTherakos, Inc.RecallAug 10, 2011FDA classification date
Therakos Cellex Procedural Kits. Designed to interface with the Cellex Photopheresis System to perform cell separation and photoactivation in a …Z-2839-2011 · LNRTherakos IncRecallJul 19, 2011FDA classification date
Therakos UVAR XTS Procedural Kits Is indicated for use in the ultraviolet-A (UVA) irradiation.Z-2067-2011 · LNRTherakos IncRecallApr 28, 2011FDA classification date
Therakos CellEx Photopheresis System; Photopheresis Procedural Kits, for use with the THERAKOS CellEx Instrument;Z-1654-2010 · LNRTherakos IncRecallMay 26, 2010FDA classification date
Therakos Photopheresis Procedural Kit for use with the UVAR XTS Instrument. (catalog number XT125)Z-1504-06 · LNRTherakos IncRecallSep 14, 2006FDA classification date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗